Synfacts, Inhaltsverzeichnis Synfacts 2023; 19(02): 0195DOI: 10.1055/s-0042-1753238 Innovative Drug Discovery and Development Design and Synthesis of a Potent, Orally Active Direct Renin Inhibitor for Hypertension Autor*innen Rezensent(en): Antonia F. Stepan (Roche) Nadine Kuhl (MSD) Danica A. Rankic (Pfizer) Artikel empfehlen Abstract Artikel einzeln kaufen(opens in new window)Key words Key wordsdirect renin inhibitor - hypertension - organocatalysis - iminium reduction Volltext
